Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v50-FR Version v41-EN
Language French English
Date Updated 2019-11-01 2019-03-08
Drug Identification Number 01919431 01919431
Brand name ENGERIX B INJ SUS 20MCG/ML ENGERIX B INJ SUS 20MCG/ML
Common or Proper name Hepatitis B vaccine (recombinant) Hepatitis B vaccine (recombinant)
Company Name GLAXOSMITHKLINE INC GLAXOSMITHKLINE INC
Ingredients HEPATITIS B SURFACE ANTIGEN HEPATITIS B SURFACE ANTIGEN
Strength(s) 20MCG 20MCG
Dosage form(s) SUSPENSION SUSPENSION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 1's 1's
ATC code J07BC J07BC
ATC description VIRAL VACCINES VIRAL VACCINES
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2017-04-06 2017-04-06
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Actual shortage
Company comments Supply unavailable in the private market. Supply available for public programs. Supply unavailable in the private market. Next supply anticipated April 22. Supply available for public programs.
Health Canada comments